1149553

Michelle Sato, M.D. — FEI 3018002804

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 13, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Los Angeles, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance